Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 462-466, January 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maudelonde, T.
Right arrow Articles by Rochefort, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maudelonde, T.
Right arrow Articles by Rochefort, H.

Immunoenzymatic Assay of Mr 52,000 Cathepsin D in 182 Breast Cancer Cytosols: Low Correlation with Other Prognostic Parameters1

Thierry Maudelonde, Siham Khalaf, Marcel Garcia, Gilles Freiss, Jacques Duporte, Marc Benatia, Hervé Rogier, Francis Paolucci, Joelle Simony, Henri Pujol, Bernard Pau and Henri Rochefort2

INSERM U 148, Unité d'Endocrinologie Cellulaire et Moléculaire, 60 Rue de Navacelles, 34100 Montpellier [T. M., M. G., G. F., J. D., Hen. R.]; Laboratoire de Biochimie Cellulaire et Hormonale, Maternité, 13 Avenue du Professeur Grasset, 34060 Montpellier [T. M., S. K., M. B., Hen. R.]; Centre Val d'Aurelle Paul Lamarque, 34094 Montpellier [J. S., H. P.]; and Sanofi-Recherche, Laboratoire Immuno Diagnostic, Rue du Professeur Joseph Blayac, 34082 Montpellier [Hen. R., F. P., B. P.], France

The Mr 52,000 cathepsin-D-like protease induced by estrogens in MCF7 human breast cells was assayed in 182 primary breast cancer cytosols prepared for receptor assays from pre- and post-menopausal patients. Using two solid-phase sandwich immunoenzymatic assays, we quantified the total Mr 52,000 cathepsin D (52K-cath-D) (the Mr 52,000 precursor protein and its Mr 48,000 and 34,000 processed forms) and the Mr 52,000 precursor alone. The value of total 52K-cath-D varied between 3 and 165 pmol/mg protein and the proportion of the precursor varied from 0 to 28% of total 52K-cath-D. There was no correlation between the concentrations of 52K-cath-D and estrogen receptor, but the estrogen receptor status (> or <10 fmol/mg protein) was correlated to the 52K-cath-D status (> or <15 pmol/mg protein) according to the x2 test (P < 0.001). The correlation with progesterone receptor concentrations and status was low (r = 0.43) and absent, respectively. There was no correlation with Scarff and Bloom stages, tumor size, or patient's age. The percentage of patients with invaded lymph nodes was significantly higher (80%) in the subgroup with the highest total 52K-cath-D levels (>=42 pmol/mg protein), representing only 12% of the population but not in the total population.

On the basis of this prospective study, before clinical follow-up can be evaluated, we conclude that in the total population examined, the 52K-cath-D concentration was only correlated with estrogen receptor status, but not with any other prognostic parameter.

1 This work was supported by the Institut National de la Santé et de la Recherche Médicale, Grant INSERM-SANOFI 81039-3, the University of Montpellier I, and the Association pour la Recherche sur le Cancer and the Pole Régional de Génie Biologique et Médical.

2 To whom requests for reprints should be addressed.

Received 2/ 6/87. Revised 6/26/87. Revised 9/23/87. Accepted 10/ 1/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.